VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020

VYNE Therapeutics reports 2020 executive compensation

By ExecPay News

Published: June 7, 2021

VYNE Therapeutics reported fiscal year 2020 executive compensation information on June 7, 2021.
In 2020, four executives at VYNE Therapeutics received on average a compensation package of $1.7M, a 42% increase compared to previous year.
Average pay of disclosed executives at VYNE Therapeutics
David Domzalski, Chief Executive Officer, received $2.9M in total. 46% of Domzalski's compensation, or $1.3M, was in stock awards. Domzalski also received $277K in bonus, $757K in option awards, $501K in salary, as well as $11K in other compensation.
Steven Basta, Chief Executive Officer, received a compensation package of $1.6M, which decreased by 14% compared to previous year. 89% of the compensation package, or $1.4M, was in other compensation.
Andrew Saik, Chief Financial Officer, earned $1.5M in 2020.
Mutya Harsch, Chief Legal Officer, received $907K in 2020.

Related executives

David Domzalski

VYNE Therapeutics

Chief Executive Officer

Steven Basta

VYNE Therapeutics

Chief Executive Officer

Andrew Saik

VYNE Therapeutics

Chief Financial Officer

Mutya Harsch

VYNE Therapeutics

Chief Legal Officer

You may also like

Source: SEC filing on June 7, 2021.